0001854078-21-000003.txt : 20210825 0001854078-21-000003.hdr.sgml : 20210825 20210825162533 ACCESSION NUMBER: 0001854078-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20210825 DATE AS OF CHANGE: 20210825 EFFECTIVENESS DATE: 20210825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Relief Therapeutics Holding SA CENTRAL INDEX KEY: 0001854078 IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-411279 FILM NUMBER: 211207154 BUSINESS ADDRESS: STREET 1: AVENUE DE SECHERON 15 CITY: CH-1202 GENEVA STATE: V8 ZIP: NA BUSINESS PHONE: 914-672-3555 MAIL ADDRESS: STREET 1: AVENUE DE SECHERON 15 CITY: CH-1202 GENEVA STATE: V8 ZIP: NA FORMER COMPANY: FORMER CONFORMED NAME: Relief Therapeutics Holding AG DATE OF NAME CHANGE: 20210329 D 1 primary_doc.xml X0708 D LIVE 0001854078 Relief Therapeutics Holding SA AVENUE DE SECHERON 15 CH-1202 GENEVA V8 SWITZERLAND NA 914-672-3555 SWITZERLAND Relief Therapeutics Holding AG Corporation true Raghuram Selvaraju Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Director Chairman of the Board of Directors Jack Weinstein Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Executive Officer Chief Financial Officer and Treasurer Gilles Della Corte Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Executive Officer Chief Medical Officer Chris Stinjen Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Executive Officer Chief Commercial Officer Taneli Jouhikainen Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Executive Officer Chief Operating Officer Tom Plitz Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Director Patrice Jean Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Director Paolo Galfetti Avenue de Secheron 15 CH-1202 Geneva V8 SWITZERLAND NA Director Pharmaceuticals $5,000,001 - $25,000,000 06c false 2021-07-28 false true false 16404000 HC Wainwright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 CA CALIFORNIA NJ NEW JERSEY false 16404000 16404000 0 Sale was made in Swiss Francs, and for purposes of this Form D converted into US Dollars at the exchange rate of 1 CHF to approximately $1.9036 USD on the date of sale. false 1 1148280 true 0 Issuer paid a fee of 7% of proceeds plus up to $100,000 in expenses. 0 false Relief Therapeutics Holding SA Jack Weinstein Jack Weinstein CFO 2021-08-25